Clinical Study | Open Access
The Effect of Oral Dexmedetomidine Premedication on Preoperative Cooperation and Emergence Delirium in Children Undergoing Dental Procedures
Introduction. The aim of this study was to detect the effect of 1 μg/kg of oral dexmedetomidine (DEX) as premedication among children undergoing dental procedures. Materials and Methods. The study involved 100 children between 2 and 6 years of age, ASA I, who underwent full-mouth dental rehabilitation. The DEX group () received 1 μg/kg DEX in apple juice, and the control group () received only apple juice. The patients’ scores on the Ramsay Sedation Scale (RSS), parental separation anxiety scale, mask acceptance scale, and pediatric anesthesia emergence delirium scale (PAEDS) and hemodynamic parameters were recorded. The data were analyzed using chi-square test, Fisher’s exact test, Student’s -test, and analysis of variance in SPSS. Results. RSS scores were significantly higher in the DEX group than group C at 15, 30, and 45 min (). More children (68% easy separation, 74% satisfactory mask acceptance) in the DEX group showed satisfactory ease of parental separation and mask acceptance behavior (). There was no significant difference in the PAEDS scores and mean hemodynamic parameters of both groups. Conclusions. Oral DEX administered at 1 μg/kg provided satisfactory sedation levels, ease of parental separation, and mask acceptance in children but was not effective in preventing emergence delirium. The trial was registered (Protocol Registration Receipt NCT03174678) at clinicaltrials.gov.
General anesthesia is frequently used in the treatment of dental caries in early childhood [1, 2]. The most recognized indications of general anesthesia are children who cannot cooperate because of a lack of psychological or emotional maturity or mental, physical, or medical disability; those for whom local anesthesia is ineffective because of acute infection, anatomic variations, or allergy; those who are extremely uncooperative, fearful, anxious, and uncommunicative; those requiring extensive surgical procedures; and those requiring immediate comprehensive dental care .
Children undergoing operation under general anesthesia may experience preoperative anxiety and may be uncooperative . Uncooperative behaviors of children may be observed at the time of separation from parents, venipuncture, or mask application. Untreated anxiety may lead to difficult induction, increased postoperative pain, greater rescue analgesic needs, emergence delirium (ED), and postoperative psychological effects and behavioral issues [4–6].
There are various agents used in the pediatric population to manage the abovementioned uncooperative behaviors, like midazolam and ketamine. Midazolam has benefits such as anticonvulsant activity, a rapid onset of action, a short duration of action, and a lower incidence of postoperative vomiting. On the other hand, its use is associated with disadvantages such as restlessness, paradoxical reactions, cognitive impairment, postoperative behavioral changes, and respiratory depression [7, 8]. Ketamine has both sedative and analgesic properties. However, adverse effects of ketamine include excessive salivation, nausea and vomiting, nystagmus, hallucination, and postoperative psychological disturbances [9, 10].
Dexmedetomidine (DEX), which is an -adrenoceptor agonist, has been used as a premedicant and analgesic in the pediatric population recently. Several previous studies have evaluated the effect of DEX as a premedicant for various surgeries. However, there is a paucity of studies evaluating the effect of DEX on preoperative anxiety and emergence delirium (ED) in dental restoration surgery [12, 18]. For this reason, the present study was designed with the aim of evaluating the effect of 1 μg/kg oral DEX on preoperative cooperation and emergence delirium in children aged 2–6 years who underwent dental procedures under general anesthesia.
2. Materials and Methods
This retrospective study was approved by the Research Ethics Committee of the Adnan Menderes University Faculty of Medicine (2017/1080). Data was collected from patients’ files and the study included the children who underwent full-mouth dental rehabilitation between December 2015 and July 2016 and were enrolled in the study.
The inclusion criteria were age between 2 and 6 years and classification as American Society of Anesthesiologists (ASA) grade 1. The exclusion criteria included congenital disease, DEX and propofol allergy, asthma, and mental retardation and those whose parents did not consent to their participation in the study.
Group DEX () included patients who received 1 μg/kg of oral DEX in apple juice 45 minutes before the induction of anesthesia, whereas group C (the control group, ) received plain apple juice orally 45 minutes before the induction of anesthesia.
2.1. Study Tools
The following tools were used in this study: the Ramsay Sedation Scale (RSS), parental separation anxiety scale (PSAS), mask acceptance scale (MAS), and the pediatric anesthesia emergence delirium scale (PAEDS). The details of the study evaluation tools and their categorization used in the study are shown in Table 1.
The children in the DEX group were observed by a blinded observer (OK) to determine their levels of sedation per the RSS before premedication and 15 minutes, 30 minutes, and 45 minutes after premedication . The same measurements made in the DEX group were conducted in group C 45 minutes before the operation.
The hemodynamic parameters, heart rate (HR), respiratory rate (RR), and SpO2, were assessed before premedication and at 15, 30, and 45 minutes after premedication.
2.2. Study Procedures
The study drug was mixed with apple juice (total volume should not exceeded 5 ml) by a nurse and administered by another nurse 45 minutes prior to being transferred to the operating room. Children in control group received only 5 ml of apple juice. The HR, RR, and SpO2 values were recorded at baseline and 15, 30, and 45 minutes after the premedication until the patient was transferred to the operating room. A research team member (SK) evaluated the ease of separation of the patients from their parents using the PSAS, approximately 45 minutes after premedication. Another member of the research team calculated the MAS score of each patient. The PAEDS score of each patient was recorded upon discharge from the PACU.
2.3. Anesthesia Protocol
All patients were intubated by the same anesthetist. Induction was carried out via a facemask with 8% sevoflurane in 100% oxygen. Following loss of consciousness, an intravenous line was established through which 2 mg/kg of 1% propofol (Propofol-Lipuro®, B. Braun Melsungen AG, Germany), 1 μg/kg of fentanyl (Talinat®, Vem, İstanbul, Turkey), and 0.5 mg/kg of rocuronium (Myocron®, Vem, Istanbul, Turkey) were administered, followed by nasotracheal intubation. The HR, noninvasive blood pressure, and SpO2 were monitored for each patient.
Anesthesia was maintained with 2% sevoflurane in a mixture of 50% oxygen and nitrous oxide. All the children received 0.4 mg/kg of tenoxicam (Tilcotil®, Deva, Istanbul, Turkey) for analgesia 15 min before the end of the surgery. The patients were extubated and transferred to the PACU. The patients were observed by a research team member during the entire period of their stay in the PACU, and a PAEDS score was recorded when the patient was fully aroused.
2.4. Dental Treatment Procedure
All the patients were treated by the same pediatric dentist (SK). Carious teeth of the patients dental treatment procedures included restorative treatment (compomer, composite, stainless steel crown, pulpotomy, and pulpectomy) or extraction if the tooth was unrestorable.
All treatments were completed in the same general anesthesia session. The durations of the dental operations were recorded in the patients’ files.
2.5. Statistical Analyses
Based on a previous study , minimum required sample size is 49 patients in each group to detect 24% (from 32% to 8%) difference in emergence delirium between DEX and control group at the 0.05 level of significance and to provide 80% power to the study and we rounded the groups up to 50 patients.
The results were presented as the mean ± standard deviation (SD) for quantitative variables and were summarized as absolute frequencies and percentages for categorical variables. Categorical variables were compared using chi-square test or Fisher’s exact test if more than 20% of cells with an expected count of less than five were observed. Quantitative variables were also compared with the Student -test. The variations in hemodynamic variables including HR, RR, and SpO2, from the baseline among the groups, were analyzed by repeated measures ANOVA.
Statistical analysis was carried out using the SPSS software version 20 (IBM Corp., Armonk, NY, USA). values of 0.05 or less were considered statistically significant.
There were no statistically significant differences between the groups regarding demographics, duration of operation, and duration of anesthesia (). The mean age of the patients was years. The demographic data of the patients are shown in Table 2.
The baseline Ramsay Sedation Scale (RSS) score was comparable in both groups (). The value of the RSS score was significantly higher in the DEX group than group C at 15, 30, and 45 min (). There was no patient with an RSS score higher than 2. Analysis of the PSAS scores demonstrated that a higher percentage (68%) of the children in the DEX group showed satisfactory response during parental separation ().
The analysis in terms of mask acceptance behavior revealed that the DEX group performed better in terms of mask acceptance behavior than group C. It was determined that 74% of the patients in the DEX group and 38% of the patients in group C had a satisfactory mask acceptance behavior and the difference between them was found to be statistically significant (). Table 3 shows the distribution and comparison of sedation satisfaction percentages of the groups in terms of time.
|Values in number (%). Significant differences between groups at 0.05 level.|
Overall, we did not observe any clinically significant effects of the study drug on SpO2 and no patient had a reduction in SpO2 to below 95% during the observation period after premedication. There was no significant differences in the mean HRs, SpO2, and RR of both groups at baseline, 15, 30, and 45 minutes (). The comparison of the mean HR, RR, and SpO2 levels of the groups during the premedication period is shown in Table 4.
|Data are presented as mean ± SD.|
There were significant group and time effects () and group time interaction on HR () in the DEX group only. The HR reduced significantly from baseline at 15, 30, and 45 minutes after drug administration in the DEX group () (Figure 1).
There was no statistically significant group and time effects and group × time interaction () on RR and SpO2 (Figures 2 and 3). In the PACU, children in the DEX group showed lower ED score compared to group C, but the difference was not statistically significant ().
This retrospective study determined that 1 μg/kg oral DEX administered as premedication to uncooperative children between the ages of 2 and 6 years who underwent full-mouth dental rehabilitation provided successful sedation at the time of parental separation and mask acceptance during the induction of anesthesia. However, no significant difference was found between both groups in terms of PAEDS scores.
Studies have shown that at least 60% of pediatric patients have preoperative anxiety . The use of sedatives in the preoperative period contributes to the reduction in the patients’ level of anxiety, prevents them from experiencing emotional trauma, and induces a calm state during induction of anesthesia.
The majority of children are able to receive dental treatment in a conventional clinical setting. Some patients who are too young or have distinctive fear fail to respond to the usual techniques such as sedation or behavioral management and must, therefore, be treated under general anesthesia [20, 21].
All of the patients included in the present study were young children who were in need of advanced dental treatment and could not be treated with sedation and behavior control techniques. Although the sedatives used in the treatment of preoperative anxiety are quite diverse, DEX has become more frequently used in children . DEX may be administered through the intravenous, oral, buccal, and intramuscular routes with bioavailabilities of 93%, 16%, 82%, and 104%, respectively .
Verma et al. compared the acceptability of the nasal and oral routes of administration of midazolam as premedication in children between 2 and 6 years of age and noted that the oral route was considerably more acceptable than the nasal route . For this reason, in this study, the DEX premedication was administered orally, and none of the children rejected taking the premedication.
There are a large number of studies on the administration routes and doses of DEX [18, 25, 26]. However, studies are still underway to determine the optimal route and dosage of DEX. Mountain et al.  compared the effect of administering 4 μg/kg of oral DEX and 0.5 mg/kg of midazolam 30 minutes before the operation on mask acceptance behavior and ease of parental separation and ED; they found no statistically significant difference between the groups. Compared to midazolam, which is the gold standard, DEX was found to be sufficient for premedication. However, previous studies noted that DEX might cause cardiovascular complications such as hypotension and bradycardia, depending on the dose and route of administration [25, 27].
Faritus et al.  compared the effects of administering 2 μg/kg of oral DEX with 0.5 mg/kg of midazolam as premedication 45 minutes preoperatively in children undergoing congenital heart surgery. A lower dose of DEX than used in previous studies showed similar sedation effects with 0.5 mg/kg of midazolam. Additionally, both agents similarly eased parental separation and mask acceptance behavior, and there were no statistically significant differences between the groups in terms of hemodynamic variables.
Similarly, in the present study, a lower dose than previous studies was used, and satisfactory sedation was achieved in 94% of patients 45 minutes after its administration. However, in 68% of the children, parental separation was eased, while, in 74%, satisfactory mask acceptance was observed. In our study, we considered an RSS score of 2 and above as adequate sedation, meaning the patients were cooperative, awake, oriented, and calm. Thus, in this study, the extent of sedation, mask acceptance, and ease of parental separation were different in comparison with previous studies.
Absorption of a drug through oral mucous membranes is also affected by many factors such as pKa, lipophilicity of a drug, and tissue perfusion and uptake. Dexmedetomidine is a highly lipophilic drug with a pKa value of 7.1 so that it is mostly in a nonionized form at physiological pH. The nonionized form of dexmedetomidine rapidly crosses biological membranes . The satisfied results obtained from our study with a low dose of dexmedetomidine administered orally for premedication may be achieved due to the fact that children did not swallow the drug immediately and held it in their mouths allowing buccal and/or sublingual absorption.
In previous studies, it has been shown that drugs used for premedication cause changes in vital findings. Kumari et al. compared the effect of 4 μg/kg of oral clonidine, 4 μg/kg of oral DEX, and 0.5 μg/kg of oral midazolam on preoperative cooperation and showed that the mean HR in all groups decreased significantly from the baseline by 30 minutes postoperatively . Yuen et al. found that the HR in children with intranasal administration of DEX as premedication decreased statistically significantly 45 minutes after its administration . In our study, there were no significant differences in the mean HR, RR, and SpO2 values after the administration of DEX.
However, in the repeated measures ANOVA, the HR in the DEX group decreased significantly 15 minutes after drug administration in comparison with group C. Despite this decrease, the values of HR remained within normal hemodynamic limits. The fact that hemodynamic variables remained within normal limits and did not differ from the control group may be because our study used a lower dose of DEX than previous studies.
ED refers to behaviors that include inconsolable crying, thrashing, kicking, disorientation, hallucinations, and cognitive and memory impairment during the recovery period following general anesthesia. These behaviors may result in falling from the bed, increased postsurgical bleeding, and contamination of the surgical wound. Additionally, this situation often requires additional nursing care, additional analgesics, or sedatives which may cause increased hospital stay. In addition, this may cause dissatisfaction of the parents. Although the etiology of ED is not fully known, the intrinsic characteristics of anesthetic agents, rapid emergence from anesthesia, postoperative pain, preschool age, preoperative anxiety, and child temperament are risk factors. Son et al. determined that, in preschool children undergoing anesthesia with sevoflurane without premedication, the incidence of ED was 60% . Özcengiz et al. showed that 2.5 mg/kg of DEX, 0.5 mg/kg of midazolam, and 0.1 mg/kg of melatonin administered orally 45 minutes preoperatively significantly reduced the incidence of ED after anesthesia with sevoflurane . In this study, the overall incidence of ED was 12% and 24% in the DEX group and group C, respectively. Previous studies indicated that the incidence of ED in preschool children varies between 25% and 80% following anesthesia with sevoflurane and desflurane [31, 32].
Sheta et al. reported that the administration of 1 μg/kg of intranasal DEX as premedication resulted in a lower incidence of ED compared to 0.2 mg/kg of intranasal midazolam in children undergoing full-mouth dental rehabilitation . Jannu et al. compared the effect of administering 4 μg/kg of oral DEX as premedication to 0.75 mg/kg of oral midazolam and they observed a lower incidence of ED in children premedicated with DEX . In a similar study, Prabhu and Mehandale reported that 4 μg/kg of oral DEX was superior to oral midazolam when given as premedication in reducing the incidence and severity of ED . Contrary to these studies, the incidence of ED in the DEX group in our study was lower than in group C, although this difference was not statistically significant.
Petroz et al. reported that the terminal half-life of intravenous DEX in children aged between 2 and 12 years was 1.8 hours . The time from the administration of DEX to the measurement of the PAEDS score in our study was longer than the terminal half-life of DEX, suggesting that there was no significant difference between both groups in terms of the incidence of ED.
This clinical study had some limitations. First limitation of this study is its retrospective design. Due to retrospective nature of the study results depended on the records in the patients’ files. Second, intravenous formulation of DEX was used as oral preparation of DEX was not available. Third, mixing of the DEX with apple juice could affect pH of the drug and its absorption. Regardless of these limitations there is a strong need for prospective studies with larger sample sizes to find optimum doses of DEX and evaluate its safety and efficacy for pediatric population.
We concluded that 1 μg/kg of oral DEX provided satisfactory sedation levels and offered significant ease of separation from parents and satisfactory mask acceptance in children. However 1 μg/kg of oral DEX was not effective in preventing emergence delirium.
Conflicts of Interest
The authors declare that there are no conflicts of interest regarding the publication of this article.
- C. Madan, E. Kruger, I. Perera, and M. Tennant, “Trends in demand for general anaesthetic care for paediatric caries in Western Australia: Geographic and socio-economic modelling of service utilisation,” International Dental Journal, vol. 60, no. 3, pp. 190–196, 2010.
- R. J. Schroth, C. Quiñonez, L. Shwart, and B. Wagar, “Treating early childhood caries under general anesthesia: A national review of Canadian data,” Journal of the Canadian Dental Association, vol. 82, article no. g20, 2016.
- Z. N. Kain, L. C. Mayes, T. Z. O'Connor, and D. V. Cicchetti, “Preoperative anxiety in children: Predictors and outcomes,” Archives of Pediatrics and Adolescent Medicine, vol. 150, no. 12, pp. 1238–1245, 1996.
- T. M. Palermo and D. Drotar, “Prediction of children's postoperative pain: The role of presurgical expectations and anticipatory emotions,” Journal of Pediatric Psychology, vol. 21, no. 5, pp. 683–698, 1996.
- K. Yuki and D. G. Daaboul, “Postoperative maladaptive behavioral changes in children,” Middle East Journal of Anesthesiology, vol. 21, no. 2, pp. 183–192, 2011.
- M. Karling, H. Stenlund, and B. Hägglöf, “Child behaviour after anaesthesia: Associated risk factors,” Acta Paediatrica, International Journal of Paediatrics, vol. 96, no. 5, pp. 740–747, 2007.
- H. Bergendahl, P.-A. Lönnqvist, and S. Eksborg, “Clonidine in paediatric anaesthesia: Review of the literature and comparison with benzodiazepines for premedication,” Acta Anaesthesiologica Scandinavica, vol. 50, no. 2, pp. 135–143, 2006.
- T. McGraw and A. Kendrick, “Oral midazolam premedication and postoperative behaviour in children,” Paediatric Anaesthesia, vol. 8, no. 2, pp. 117–121, 1998.
- T. A. Bowdle, A. D. Radant, D. S. Cowley, E. D. Kharasch, R. J. Strassman, and P. P. Roy-Byrne, “Psychedelic effects of ketamine in healthy volunteers: Relationship to steady-state plasma concentrations,” Anesthesiology, vol. 88, no. 1, pp. 82–88, 1998.
- P. J. Donahue and P. S. Dineen, “Emergence delirium following oral ketamine,” Journal of the American Society of Anesthesiologists, vol. 77, no. 3, p. 604, 1992.
- M. A. Ramsay, T. M. Savege, B. R. Simpson, and R. Goodwin, “Controlled sedation with alphaxalone-alphadolone,” British Medical Journal, vol. 2, no. 920, pp. 656–659, 1974.
- B. W. Mountain, L. Smithson, M. Cramolini, T. H. Wyatt, and M. Newman, “Dexmedetomidine as a pediatric anesthetic premedication to reduce anxiety and to deter emergence delirium,” AANA Journal, vol. 79, no. 3, pp. 219–224, 2011.
- B. Isik, M. Arslan, A. D. Tunga, and O. Kurtipek, “Dexmedetomidine decreases emergence agitation in pediatric patients after sevoflurane anesthesia without surgery,” Paediatric Anaesthesia, vol. 16, no. 7, pp. 748–753, 2006.
- B. C. Weldon, M. F. Watcha, and P. F. White, “Oral midazolam in children: Effect of time and adjunctive therapy,” Anesthesia and Analgesia, vol. 75, no. 1, pp. 51–55, 1992.
- M. Shukry, M. C. Clyde, P. L. Kalarickal, and U. Ramadhyani, “Does dexmedetomidine prevent emergence delirium in children after sevoflurane-based general anesthesia?” Paediatric Anaesthesia, vol. 15, no. 12, pp. 1098–1104, 2005.
- H.-S. Na, I.-A. Song, J.-W. Hwang, S.-H. Do, and A.-Y. Oh, “Emergence agitation in children undergoing adenotonsillectomy: A comparison of sevoflurane vs. Sevoflurane-remifentanil administration,” Acta Anaesthesiologica Scandinavica, vol. 57, no. 1, pp. 100–105, 2013.
- N. Sikich and J. Lerman, “Development and psychometric evaluation of the paediatric anesthesia emergence delirium scale,” Anesthesiology, vol. 100, no. 5, pp. 1138–1145, 2004.
- S. A. Sheta, M. A. Al-Sarheed, and A. A. Abdelhalim, “Intranasal dexmedetomidine vs midazolam for premedication in children undergoing complete dental rehabilitation: a double-blinded randomized controlled trial,” Paediatric Anaesthesia, vol. 24, no. 2, pp. 181–189, 2014.
- D. Özcengiz, Y. Gunes, and O. Ozmete, “Oral melatonin, dexmedetomidine, and midazolam for prevention of postoperative agitation in children,” Journal of Anesthesia, vol. 25, no. 2, pp. 184–188, 2011.
- C. DiMaggio, L. S. Sun, and G. Li, “Early childhood exposure to anesthesia and risk of developmental and behavioral disorders in a sibling birth cohort,” Anesthesia and Analgesia, vol. 113, no. 5, pp. 1143–1151, 2011.
- B. Jankauskiene, J. I. Virtanen, R. Kubilius, and J. Narbutaite, “Oral health-related quality of life after dental general anaesthesia treatment among children: A follow-up study,” BMC Oral Health, vol. 14, no. 1, article no. 81, 2014.
- K. Peng, S. R. Wu, F. H. Ji, and J. Li, “Premedication with dexmedetomidine in pediatric patients: a systematic review and meta-analysis,” Clinics, vol. 69, no. 11, pp. 777–786, 2014.
- M. Anttila, J. Penttilä, A. Helminen, L. Vuorilehto, and H. Scheinin, “Bioavailability of dexmedetomidine after extravascular doses in healthy subjects,” British Journal of Clinical Pharmacology, vol. 56, no. 6, pp. 691–693, 2003.
- R. K. Verma, A. Paswan, A. De, and S. Gupta, “Premedication with midazolam nasal spray: An alternative to oral midazolam in children,” Anesthesiology and Pain Medicine, vol. 1, no. 4, pp. 248–251, 2012.
- V. M. Yuen, T. W. Hui, M. G. Irwin, and M. K. Yuen, “A comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric anesthesia: A double-blinded randomized controlled trial,” Anesthesia and Analgesia, vol. 106, no. 6, pp. 1715–1721, 2008.
- S. Z. Faritus, M. Khazaee-Koohpar, M. Ziyaeifard, and M. J. Mehrabanian, “Oral dexmedetomidine versus midazolam as anesthetic premedication in children undergoing congenital heart surgery,” Anesthesiology and Pain Medicine, vol. 5, no. 3, Article ID e25032, 2015.
- J. W. Berkenbosch and J. D. Tobias, “Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin,” Pediatric Critical Care Medicine, vol. 4, no. 2, pp. 203–205, 2003.
- L. C. P. Santos, J. W. Ludders, H. N. Erb, K. L. Basher, P. Kirch, and R. D. Gleed, “Sedative and cardiorespiratory effects of dexmedetomidine and buprenorphine administered to cats via oral transmucosal or intramuscular routes,” Veterinary Anaesthesia and Analgesia, vol. 37, no. 5, pp. 417–424, 2010.
- S. Kumari, N. Agrawal, G. Usha, V. Talwar, and P. Gupta, “Comparison of oral clonidine, oral dexmedetomidine, and oral midazolam for premedication in pediatric patients undergoing elective surgery,” Anesthesia: Essays and Researches, vol. 11, no. 1, p. 185, 2017.
- J.-S. Son, E. Jang, M. W. Oh, J.-H. Lee, Y. J. Han, and S. Ko, “A comparison of postoperative emergence agitation between sevoflurane and thiopental anesthesia induction in pediatric patients,” Korean Journal of Anesthesiology, vol. 68, no. 4, pp. 373–378, 2015.
- T. Voepel-Lewis, S. Malviya, and A. R. Tait, “A prospective cohort study of emergence agitation in the pediatric postanesthesia care unit,” Anesthesia and Analgesia, vol. 96, no. 6, pp. 1625–1630, 2003.
- G. P. Vlajkovic and R. P. Sindjelic, “Emergence delirium in children: Many questions, few answers,” Anesthesia and Analgesia, vol. 104, no. 1, pp. 84–91, 2007.
- V. Jannu, R. Mane, M. Dhorigol, and C. Sanikop, “A comparison of oral midazolam and oral dexmedetomidine as premedication in pediatric anesthesia,” Saudi Journal of Anaesthesia, vol. 10, no. 4, pp. 390–394, 2016.
- M. Prabhu and S. Mehandale, “Comparison of oral dexmedetomidine versus oral midazolam as premedication to prevent emergence agitation after sevoflurane anaesthesia in paediatric patients,” Indian Journal of Anaesthesia, vol. 61, no. 2, p. 131, 2017.
- G. C. Petroz, N. Sikich, M. James et al., “A phase I, two-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children,” Anesthesiology, vol. 105, no. 6, pp. 1098–1110, 2006.
Copyright © 2017 Sultan Keles and Ozlem Kocaturk. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.